Did you know, it is predicted that myopia alone will impact nearly half the global population by 2050? With that in mind, Zhaoke Ophthalmology has developed a new innovative drug, NVK002, that seeks to address this concern. 

Join in the conversation with Dan Koh and Zia-ul Raushan as they invite Lisa Feng, CFO, Zhaoke Ophthalmology on today’s episode of Money and Me to talk about what her company is doing to position themselves as a market leader in this space and the opportunities presented to investors looking to dabble in the world of eye health.